Accropeutics Secured $12 Million in Series B Plus Financing

Accropeutics Secured $12 Million in Series B Plus Financing

Approximately $12 million additional financing led by Shenzhen Capital Group (SCGC), with participation from existing investor Morningside Ventures, and new investors Leader Venture Investment (SZTI) and Hefei Sci-Tec Venture Capital (HFST). Cash...

menu
menu